As Constuction.RU was told today by the press office of the regional administration, a plot for land intended for construction site of a new enterprise is being currently prepared. Apart from that, equipment estimated at 613,8 million rubles ($10,6 million) has already been purchased to ensure production of antidiabetic drugs.
We should remind you that Pharmasintez JSC is among top 10 Russian leading pharmaceutical enterprises in terms of dynamics of drugs production. The company has been operating on pharmaceutical market since 1997. It engages in development and production of cancer, tuberculosis and AIDS drugs.